Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of intravenous single ascending doses of IM-250 in healthy volunteers.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523146-27-00

Acronym

IM-104

Enrollment

Registered

2025-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes simplex virus encephalitis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026